Search Results - Thomas Capozza

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial by Thomas Capozza, Jennifer Burkey, Jeroen Van De Wetering, Reinhold Kerb, Jennifer Callahan, Ludmila Kryzhanovskaya, Mary Erickson

    Published 2025
    Get full text
    Artículo Open Access

    Save to List
    Saved in:

Search Tools: